New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
16:27 EDTNKE, DD, FINL, MNKD, MTW, DG, AMEDOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a late day rise allowed all of the major averages to end the week on a high note. The averages began the session in negative territory but soon turned mixed. The Nasdaq was able to hold its head above water for most of the session while the Dow struggled for most of the day under the weight of DuPont (DD) shares, which were down more than 3% after the company lowered its guidance. ECONOMIC EVENTS: In the U.S., the final University of Michigan consumer sentiment index for June rose to 82.5, which beat the consensus expectation for a reading of 81.9. COMPANY NEWS: Shares of athletic apparel and footwear giant Nike (NKE) and sports shoe retailer Finish Line (FINL) climbed after both companies reported better than expected quarterly sales and profits. Dow member Nike rose 82c, or 1.07%, to $77.68, while Finish Line advanced 41c, or 1.41%, to $29.56... Another member of the Dow Jones Industrial Average, DuPont, moved in the opposite direction, falling $2.26, or 3.34%, to $65.44 after the industrial conglomerate cut its earnings outlook for its second quarter and its current fiscal year. MAJOR MOVERS: Among the notable gainers was Amedisys (AMED), which rose $4.01, or 29.81%, to $17.46 and was upgraded at CRT Capital after the company gave Q2 guidance. Also higher was Manitowoc (MTW), which gained $3.22, or 10.84%, to $32.93 and was upgraded to Hold at Jefferies after activist Relational Investors took an 8.5% stake in the company and urged for a spin-off of its food business. Among the noteworthy losers was discount retailer Dollar General (DG), which fell $4.49, or 7.28%, to $57.19 after Chief Executive Officer Rick Dreiling announced plans to retire. Also lower were shares of MannKind (MNKD), which dropped 58c, or 5.48%, to $10.00 after the FDA approved its Afrezza inhalation powder to treat diabetes but required the drug to have a Boxed Warning and required the company to conduct several post-marketing studies on the drug. INDEXES: The Dow was up 5.71, or 0.03%, to 16,851.84, the Nasdaq was up 18.88, or 0.43%, to 4,397.93, and the S&P 500 was up 3.74, or 0.19%, to 1,960.96.
News For NKE;DD;FINL;MNKD;MTW;DG;AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 20, 2014
06:52 EDTMNKDMannKind initiated with a Neutral at Goldman
Target $6.
October 17, 2014
16:09 EDTDGElliott Advisors expresses concerns over Family Dollar merger, nominates slate
Subscribe for More Information
10:00 EDTDGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:11 EDTDGDollar General initiated with a Buy at Stifel
Subscribe for More Information
October 16, 2014
14:13 EDTDDU.S farmers use less fertilizer this autumn as crop prices fade, Reuters says
Subscribe for More Information
07:04 EDTDGDollar General to build new distribution center in San Antonio, TX
Subscribe for More Information
October 15, 2014
10:02 EDTNKEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:28 EDTNKENike upgraded to Conviction Buy from Buy at Goldman
Subscribe for More Information
06:12 EDTNKENike's Converse sues rivals over 'copycat' design, NY Post reports
Converse, a unit of Nike (NKE), is suing rivals including Ralph Lauren (RL) and Tory Burch, alleging that shoemakers and retailers are copying its iconic design, the New York Post reports. Lawyers for Converse say "We welcome fair competition, but we do not believe companies have a right to copy the trademarked look." The lawsuit seeks unspecified damages and injunctions that would bar the production of the rival shoe models. Reference Link
October 13, 2014
07:50 EDTMTWManitowoc price target lowered to $27 from $33 at RBC Capital
Subscribe for More Information
October 10, 2014
16:17 EDTDGDollar General receives second request from FTC
Subscribe for More Information
13:08 EDTMTWOn The Fly: Midday Wrap
Stocks on Wall Street opened in negative territory and saw several swings throughout the morning. Near midday the averages were mixed, with the Dow a bit higher and the Nasdaq weighed down by weakness across the semiconductor sector. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. COMPANY NEWS: Shares of a number of semiconductor makers, including industry giant Intel (INTC), were sharply lower after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future. Near noon, Microchip dropped 11%, Intel fell almost 4%, Texas Instruments (TXN) slipped over 6%, Micron (MU) dropped 6% and Fairchild (FCS) declined 12%. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied 35% after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Among the noteworthy losers were a number of companies that, similarly to Microchip, warned that their quarterly results will likely miss expectations, including Procera Networks (PKT), which plunged 34%, Manitowoc (MTW), which fell 9%, and Sizmek (SZMK), which dropped 21%. INDEXES: Near midday, the Dow was up 38.02, or 0.23%, to 16,697.27, the Nasdaq was down 35.89, or 0.82%, to 4,342.45, and the S&P 500 was up 0.42, or 0.02%, to 1,928.63.
12:05 EDTDDUSDA raises U.S. corn production estimate to 14.475B
Subscribe for More Information
10:01 EDTMTWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:01 EDTDDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:00 EDTMTWOn The Fly: Pre-market Movers
Subscribe for More Information
08:36 EDTMTWManitowoc downgraded at BMO Capital
Subscribe for More Information
08:11 EDTDGFamily Dollar Q4 bad enough to justify merger, says FBR Capital
Subscribe for More Information
06:29 EDTMTWManitowoc downgraded to Underperform from Market Perform at BMO Capital
05:43 EDTDDDuPont upgraded to Buy from Hold at Jefferies
Jefferies upgraded DuPont to Buy citing the pullback in shares and its belief the company's capital return program should sustain low-teens earnings growth. The firm raised its price target for shares to $84 from $72.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use